We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CPG:LSECompass Group PLC Analysis

Data as of 2026-03-10 - not real-time

£2,283.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Compass Group trades at £2,283, comfortably above its 200‑day SMA of £2,447, indicating a longer‑term bearish bias despite a current price above the 20‑day (£2,184) and 50‑day (£2,231) averages. The RSI sits at 58, suggesting neutral momentum, while the MACD histogram remains strongly positive, giving a short‑term bullish signal. Volatility is elevated at over 30% for the past 30 days, but the beta of 0.17 points to low market‑wide sensitivity. A DCF‑derived fair value of £1,720 places the stock well above intrinsic estimates, and the PE of 27.8× further signals a premium valuation. The company posted 7% organic revenue growth in Q1 FY26 with 96% client retention, yet shares slipped 3% on concerns over a slowdown and AI‑related disruption. Analysts’ median target of £2,982 implies roughly 24% upside, though the high debt‑to‑equity ratio of 90.7% and a P/B of 673 raise valuation caution.
The dividend yield of 2.12% and a payout ratio near 56% provide modest income, but leverage and a max drawdown of 24% suggest risk. The “Extreme Greed” sentiment on the Fear & Greed Index reflects strong market appetite, potentially inflating price. Overall, the stock presents a mixed picture: short‑term technical optimism against a backdrop of overvaluation and sector volatility. Investors should weigh the solid cash‑flow generation and client base against the elevated leverage and valuation gaps. The consensus recommendation remains a “buy,” but execution timing is critical. Maintaining a disciplined approach to entry levels near support (£2,000) could improve risk‑adjusted returns.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Technical bullish MACD vs longer‑term bearish SMA placement
  • Recent earnings beat but share price dip on growth concerns
  • High valuation relative to DCF and elevated volatility

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Analyst median target indicating ~24% upside
  • Sustained 7% organic revenue growth and high client retention
  • Attractive dividend yield supporting total return

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Diversified global service portfolio reduces cyclical exposure
  • Strong cash‑flow generation despite leverage
  • Long‑term secular demand for outsourced food and facilities services

Key Metrics & Analysis

Financial Health

Revenue Growth10.60%
Profit Margin4.05%
P/E Ratio27.8
ROE25.64%
ROA7.42%
Debt/Equity90.71
P/B Ratio673.4
Op. Cash Flow£3.4B
Free Cash Flow£1.6B

Technical Analysis

TrendBearish
RSI58.0
Support£2,000.00
Resistance£2,326.00
MA 20£2,184.10
MA 50£2,231.42
MA 200£2,447.13
MACDBullish
VolumeStable
Fear & Greed Index75.89

Valuation

Fair Value£1,719.80
Target Price£2,834.49
Upside/Downside24.16%
GradeOvervalued
TypeBlend
Dividend Yield2.12%

Risk Assessment

Beta0.17
Volatility30.52%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.